These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 30504713
21. Myo-inositol oxygenase accentuates renal tubular injury initiated by endoplasmic reticulum stress. Tominaga T, Sharma I, Fujita Y, Doi T, Wallner AK, Kanwar YS. Am J Physiol Renal Physiol; 2019 Feb 01; 316(2):F301-F315. PubMed ID: 30539651 [Abstract] [Full Text] [Related]
22. Myo-inositol Oxygenase (MIOX) Overexpression Drives the Progression of Renal Tubulointerstitial Injury in Diabetes. Sharma I, Deng F, Liao Y, Kanwar YS. Diabetes; 2020 Jun 01; 69(6):1248-1263. PubMed ID: 32169892 [Abstract] [Full Text] [Related]
23. Does serum kidney injury molecule-1 predict early diabetic nephropathy: A comparative study with microalbuminuria. Balu D, Krishnan V, Krishnamoorthy V, Singh RBS, Narayanasamy S, Ramanathan G. Ann Afr Med; 2022 Jun 01; 21(2):136-139. PubMed ID: 35848645 [Abstract] [Full Text] [Related]
24. Urine Haptoglobin/Creatinine Ratio Correlates with Tubular Injury Biomarkers and Severity of Albuminuria in Type 2 Diabetes Patients. Wang Y, Zhou Q, Zhang L, Dai Y, Huang Z, Zhang H, Yi B. Horm Metab Res; 2019 Sep 01; 51(9):595-601. PubMed ID: 31505705 [Abstract] [Full Text] [Related]
25. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, Zheng L, Wang SB, Pen LF, Wang Q. Endocrine; 2012 Feb 01; 41(1):82-8. PubMed ID: 21779943 [Abstract] [Full Text] [Related]
26. Development of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injury. Gaut JP, Crimmins DL, Ohlendorf MF, Lockwood CM, Griest TA, Brada NA, Hoshi M, Sato B, Hotchkiss RS, Jain S, Ladenson JH. Clin Chem; 2014 May 01; 60(5):747-57. PubMed ID: 24486646 [Abstract] [Full Text] [Related]
27. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition. El-Dawla NMQ, Sallam AM, El-Hefnawy MH, El-Mesallamy HO. Clin Exp Nephrol; 2019 Aug 01; 23(8):1050-1057. PubMed ID: 31104272 [Abstract] [Full Text] [Related]
28. Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy. Chen J, Zhang WW, Chen KH, Lin LR, Dai HZ, Li KL, Zhang JG, Zheng LQ, Fu BQ, He YN. Am J Physiol Renal Physiol; 2017 Aug 01; 313(2):F273-F281. PubMed ID: 28356293 [Abstract] [Full Text] [Related]
29. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy. Elkholy RA, Younis RL, Allam AA, Hagag RY, Abdel Ghafar MT. J Investig Med; 2021 Aug 01; 69(6):1189-1195. PubMed ID: 33863755 [Abstract] [Full Text] [Related]
30. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y. Diabetes Metab Res Rev; 2009 Mar 01; 25(3):232-41. PubMed ID: 19177462 [Abstract] [Full Text] [Related]
31. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A, Bdeer Sel-A, El-Sokkary RH. Mol Cell Biochem; 2015 Oct 01; 408(1-2):25-35. PubMed ID: 26104579 [Abstract] [Full Text] [Related]
32. Effectiveness of myo-inositol oxygenase in the early diagnosis of experimental acute kidney injury. Mertoglu C, Ozmen ZC, Firat F, Arici A, Unsal V, Erdemir F. Bratisl Lek Listy; 2020 Oct 01; 121(8):565-570. PubMed ID: 32726119 [Abstract] [Full Text] [Related]
33. Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI. Dutta RK, Kondeti VK, Sharma I, Chandel NS, Quaggin SE, Kanwar YS. J Am Soc Nephrol; 2017 May 01; 28(5):1421-1436. PubMed ID: 27895157 [Abstract] [Full Text] [Related]
34. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. Lacquaniti A, Donato V, Pintaudi B, Di Vieste G, Chirico V, Buemi A, Di Benedetto A, Arena A, Buemi M. Acta Diabetol; 2013 Dec 01; 50(6):935-42. PubMed ID: 23754672 [Abstract] [Full Text] [Related]
35. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. Yu H, Wang H, Su X, Cao A, Yao X, Wang Y, Zhu B, Wang H, Fang J. BMC Nephrol; 2022 Jan 21; 23(1):41. PubMed ID: 35062888 [Abstract] [Full Text] [Related]
36. Renal depletion of myo-inositol is associated with its increased degradation in animal models of metabolic disease. Chang HH, Chao HN, Walker CS, Choong SY, Phillips A, Loomes KM. Am J Physiol Renal Physiol; 2015 Nov 01; 309(9):F755-63. PubMed ID: 26311112 [Abstract] [Full Text] [Related]
37. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Żyłka A, Dumnicka P, Kuśnierz-Cabala B, Gala-Błądzińska A, Ceranowicz P, Kucharz J, Ząbek-Adamska A, Maziarz B, Drożdż R, Kuźniewski M. Mediators Inflamm; 2018 Nov 01; 2018():7659243. PubMed ID: 30158836 [Abstract] [Full Text] [Related]
38. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy. Wang Y, Li YM, Zhang S, Zhao JY, Liu CY. J Int Med Res; 2016 Apr 01; 44(2):278-86. PubMed ID: 26857862 [Abstract] [Full Text] [Related]
39. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria. Hafez MH, El-Mougy FA, Makar SH, Abd El Shaheed S. Iran J Kidney Dis; 2015 Mar 01; 9(2):126-31. PubMed ID: 25851291 [Abstract] [Full Text] [Related]
40. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy. Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, Bell GM. Ren Fail; 1995 Jan 01; 17(1):43-9. PubMed ID: 7770643 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]